mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.014 |
0.8 |